Cargando…
COVID-19, corticosteroids and public health: a reappraisal
OBJECTIVES: To assess whether regulatory guidance on the use of dexamethasone in hospitalised COVID-19 patients is applicable to the larger population of COVID-19 cases. The surge in worldwide demand for dexamethasone suggests that the guidance, although correct, has not emphasised the danger of its...
Autores principales: | Fernandes, M., Brábek, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society for Public Health. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180552/ https://www.ncbi.nlm.nih.gov/pubmed/34325124 http://dx.doi.org/10.1016/j.puhe.2021.05.028 |
Ejemplares similares
-
A reappraisal of corticosteroids use for COVID-19
por: Pati, Ilaria, et al.
Publicado: (2022) -
A reappraisal of public engagement in Oxford during the pandemic: three case studies
por: Farrell, Milly, et al.
Publicado: (2022) -
Antenatal corticosteroids: a reappraisal of the drug formulation and dose
por: Jobe, Alan H., et al.
Publicado: (2020) -
Fertility Counseling in Survivors of Cancer in Childhood and Adolescence: Time for a Reappraisal?
por: Filippi, Francesca, et al.
Publicado: (2021) -
COVID-19 vaccination: science, politics and public health
por: Wright, J. Tim
Publicado: (2021)